Entity Common Stock, Shares Outstanding of UroGen Pharma Ltd. from 31 Dec 2017 to 24 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
UroGen Pharma Ltd. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Dec 2017 to 24 Feb 2026.
  • UroGen Pharma Ltd. Entity Common Stock, Shares Outstanding for the quarter ending 24 Feb 2026 was 48,682,280, a 5.6% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

UroGen Pharma Ltd. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 48,682,280 +2,574,829 +5.6% 24 Feb 2026 10-K 02 Mar 2026 2025 FY
Q3 2025 46,808,892 +4,609,478 +11% 31 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 46,264,132 +4,150,062 +9.9% 31 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 46,107,451 +9,977,330 +28% 23 Apr 2025 10-K/A 30 Apr 2025 2024 FY
Q3 2024 42,199,414 +11,333,094 +37% 01 Nov 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 42,114,070 +11,831,190 +39% 05 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 36,130,121 +12,689,600 +54% 22 Apr 2024 10-K/A 29 Apr 2024 2023 FY
Q3 2023 30,866,320 +7,776,281 +34% 07 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 30,282,880 +7,542,354 +33% 07 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 23,440,521 +747,351 +3.3% 20 Mar 2023 10-K 24 Mar 2023 2022 FY
Q3 2022 23,090,039 +669,714 +3% 07 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 22,740,526 +377,503 +1.7% 05 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 22,693,170 +412,776 +1.9% 03 May 2022 10-Q 10 May 2022 2022 Q1
Q3 2021 22,420,325 +327,271 +1.5% 03 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 22,363,023 +339,224 +1.5% 27 Jul 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 22,280,394 +345,263 +1.6% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q3 2020 22,093,054 +1,113,474 +5.3% 04 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 22,023,799 +1,125,986 +5.4% 05 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 21,935,131 +1,143,686 +5.5% 04 May 2020 10-Q 07 May 2020 2020 Q1
Q3 2019 20,979,580 04 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 20,897,813 05 Aug 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 20,791,445 07 May 2019 10-Q 09 May 2019 2019 Q1
Q4 2017 13,751,390 31 Dec 2017 20-F 15 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.